Aussie researchers have developed an interactive "toy" that diverts kids' attention from pain when their dressings are changed.
Ditto's designers at the Queensland University of Technology in Brisbane describe it as a circular touch-screen unit that uses motion sensors and vibration feedback to maximises sensory distraction when children's dressings are changed.
Practice Nurse Policy Makes Perfect Sense
Today's Government announcements on general practice nurses will assist GPs in providing care for patients.
Advertisement
A child tilts the gadget to navigate through a story or game as they search for hidden objects along the way.
He/she can even look underneath things by tipping the Ditto upside-down.
"They get really engrossed, rotating the device and zooming in and out," New Scientist magazine quoted project leader Sam Bucolo as saying.
Source: ANI
SPH/L
"They get really engrossed, rotating the device and zooming in and out," New Scientist magazine quoted project leader Sam Bucolo as saying.
Source: ANI
SPH/L
Nanotechnology Used to Eliminate Odors in Socks Harm Environment
Nanotechnology used to kill bacteria and eliminate odors in socks, food containers, medical dressings and even teddy bears might be harmful to the environment.
Advertisement
 Stitches Laced With Bacteria-killing Viruses Could Fight Back MRSAA new way to counter the dreaded MRSA seems to have been found - stitches and dressings laced with bacteria-killing viruses. | Advertisement
|
Advertisement
Recommended Readings
Latest Research News
South Korea's total fertility rate, averaging the number of children a woman aged 15-49 has in her lifetime, dropped to 0.81.
Scientists identified mechanisms governing immune cells, selectively removing troublemakers to reshape skin immunity. Benefits those with psoriasis, vitiligo.
By 2050, an anticipated increase from 494 million cases in 2020 to 1.06 billion people with musculoskeletal disabilities is expected.
Experts consulted by GlobalData anticipate a significant overhaul in the Gaucher disease scenario because of forthcoming gene therapies in development.
Within the seven major markets, 12% to 20% of diagnosed prevalent NASH cases present severe liver damage (stage 4 liver fibrosis), denoting cirrhosis.